Minimally-Invasive and Efficient Method to Accurately Fit the Bergman Minimal Model to Diabetes Type 2.
Cell Mol Bioeng
; 15(3): 267-279, 2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35611162
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cell Mol Bioeng
Year:
2022
Document type:
Article
Affiliation country:
Mexico
Country of publication:
United States